Life Sci VC
IPO News: The Rising Tide Of Biotech IPO Valuations - Life Sci VC
Life Sci VC

The biotech IPO market continues to march forward, with five new offerings expected to price in the next week or so. Investor demand for stories advancing novel innovative therapies remains at historic levels – extending what is now over a six-year window for biotech IPOs.

To frame up how the IPO markets have evolved over the past six years, it’s worth reviewing the data around the changes to pre-money valuations over time.  The trend line is clear: up and to the right.

At least two observations from these data are worth noting.

Full article can be found here